HomeIDIA • SWX
add
Idorsia Ltd
Previous close
CHF 1.24
Day range
CHF 1.11 - CHF 1.20
Year range
CHF 0.61 - CHF 2.98
Market cap
212.77M CHF
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 59.90M | 178.42% |
Operating expense | 66.24M | -15.25% |
Net income | -83.89M | 28.10% |
Net profit margin | -140.05 | 74.18% |
Earnings per share | — | — |
EBITDA | -54.75M | 51.22% |
Effective tax rate | 0.29% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.36M | -21.20% |
Total assets | 505.72M | 1.14% |
Total liabilities | 1.72B | 16.96% |
Total equity | -1.21B | — |
Shares outstanding | 188.74M | — |
Price to book | -0.19 | — |
Return on assets | -28.93% | — |
Return on capital | -166.00% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -83.89M | 28.10% |
Cash from operations | -11.00M | 90.09% |
Cash from investing | -736.00K | -101.41% |
Cash from financing | 26.19M | — |
Net change in cash | -38.68M | 35.78% |
Free cash flow | 26.92M | 129.47% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
